Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

Journal:
Journal of Clinical Oncology
Published:
DOI:
10.1200/jco-25-00835
Affiliations:
20
Authors:
25
Go to article
Institutions Authors Share
Institute Gustave-Roussy (IGR), France
6.000000
 0.24
Georges Pompidou European Hospital (HEGP), France
5.833333
 0.23
UNICANCER Group, France
3.000000
 0.12
Paris-Cardiovascular Research Center (PARCC), France
2.333333
 0.09
Cordelier Research Center (CRC), France
2.000000
 0.08
Centre for Research in Epidemiology and Population Health (CESP), France
1.500000
 0.06
Lorraine Institute of Oncology (ICL), France
1.000000
 0.04
Centre Léon Bérard (CLB), France
1.000000
 0.04
Centre Henri Becquerel, France
1.000000
 0.04
Institut Sainte Catherine, France
1.000000
 0.04
Paris Cité University, France
0.333333
 0.01
Interested in Oncology and Carcinogenesis?